Entering text into the input field will update the search result below

Cara Therapeutics, Inc. (CARA) CEO Christopher Posner on Q4 2021 Results - Earnings Call Transcript

Mar. 01, 2022 8:58 PM ETCara Therapeutics, Inc. (CARA)
SA Transcripts profile picture
SA Transcripts

Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET

Company Participants

Iris Francesconi - Interim Head, Investor Relations

Christopher Posner - President, CEO & Director

Thomas Reilly - CFO

Joana Goncalves - Chief Medical Officer

Conference Call Participants

Joseph Stringer - Needham & Company

Nicholas Rubino - Stifel, Nicolaus & Company

Sumant Kulkarni - Canaccord Genuity

Chi Zhang - Bank of America Merrill Lynch

Daniel Wolle - JPMorgan Chase & Co.

David Amsellem - Piper Sandler & Co.

Kambiz Yazdi - Jefferies


Good afternoon. My name is Andrew, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics Fourth Quarter 2021 Financial Results and Update Conference Call. All lines have been placed on mute to avoid any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Please be advised that this call is being recorded.

I would now like to introduce Iris Francesconi, Interim Head of Investor Relations from Cara Therapeutics. Ms. Framcesconi, you may begin your call.

Iris Francesconi

Thank you, Andrew, and good afternoon. Just after market closed today, we issued a press release detailing our corporate progress and financial results for the fourth quarter and full year 2021. The press release can be found on our website at www.caratherapeutics.com. You may also listen to a live webcast and replay of today's call on the Investors section of the website. Participating in today's call are Chris Posner, Cara's President and Chief Executive Officer; Tom Reilly, Cara's Chief Financial Officer; and Joana Goncalves, Cara's Chief Medical Officer.

Before we begin, let me remind you that statements made on today's call regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.